マーケットレポート詳細
がん幹細胞：技術および世界市場2026年予測
Cancer Stem Cells: Technologies and Global Markets
- 出版元：BCC Research
出版元について - 発行年：2021年12月
- 定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文206ページになります。
- 商品コード：BCC353
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
がん幹細胞の世界市場規模は2021年で21億ドル、2026年に44億ドル、市場の平均年成長率は16.1%で推移する見込みです。
がん幹細胞市場における研究開発活動の増加は、CSCに関する研究者の知識を向上させ、従来型がん治療の効率を上げるための標的として、がん幹細胞をどのように使用できるかを改善することに役立ちます。しかし、市場成長を妨げる可能性の要因として、幹細胞に関連する倫理的問題とがん細胞治療に関する高コストがあります。また、前臨床試験中の動物モデルでのCSC治療の成功実現は、市場成長のための新たな道を開くことに役立つでしょう。
当レポートでは、がん幹細胞の市場/技術的背景、市場ダイナミクス、各種セグメント別市場分析(タイプ別、国地域別)、COVID-19と幹細胞研究、2021年の幹細胞治療の費用、競合状況、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
◆イントロダクション
・調査目的
・調査対象
・調査手法
◆サマリーと調査ハイライト
◆市場/技術的背景
・市場の定義と範囲
・がん幹細胞(CSC)の歴史
・CSCの合成、単離および同定
・がん幹細胞の特徴
・幹細胞の分類
・作用機序
・幹細胞移植
・がん幹細胞の臨床パイプライン
◆市場ダイナミクス
・ドライバー
・障壁
・機会
◆がん幹細胞市場、タイプ別
・肺がん
・乳がん
・結腸直腸がん
・白血病
・黒色腫
・前立腺がん
・脳腫瘍
・骨肉腫
・その他
※市場予測データ-2026年掲載
◆がん幹細胞市場、国地域別
北米
・米国、カナダ、メキシコ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア
・その他アジア太平洋
その他地域
・ブラジル
・GCC諸国
・その他
※市場予測データ-2026年掲載
※地域別にタイプ別のデータ掲載
◆COVID-19と幹細胞研究
・初期段階の研究の影響
・COVID-19の主流医薬品への幹細胞の進歩
・COVID-19治療のための幹細胞の未来
◆2021年の幹細胞治療の費用
・幹細胞治療の種類
・幹細胞治療はなぜ高額なのか
・幹細胞治療の倫理と規制
◆競合状況
・グローバル企業ランキング分析
・再生治療または幹細胞治療のスタートアップ
◆主要企業プロフィール
・ADNAGEN AG
・ADVANCED CELL DIAGNOSTICS INC.
・APCETH BIOPHARMA
・AVIVA BIOSCIENCES CORP.
・BIONTECH
・BENITEC BIOPHARMA
・CALADRIUS BIOSCIENCES
・CELGENE CORP.
・EPIC SCIENCES INC.
・EXCELLTHERA
・FLUXION BIOSCIENCES INC.
・GALENA BIOPHARMA
・GAMIDA CELL
・GENEXINE
・GERON
・IMMUNOCELLULAR THERAPEUTICS
・ONCOCYTE CORP.
・ONCOMED PHARMACEUTICALS INC.
・PLURISTEM THERAPEUTICS INC.
・SILICON BIOSYSTEMS S.P.A
・SPHERE FLUIDICS LTD.
・VIACYTE INC.
・VITATEX INC.
◆特許一覧
・がん幹細胞に関する北米特許
・がん幹細胞に関する欧州特許
・がん幹細胞に関するアジア太平洋特許
・がん幹細胞に関するその他地域特許
(全206頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Market Definition and Scope
History of Cancer Stem Cells
Synthesis, Isolation and Identification of CSCs
Characteristics of Cancer Stem Cells
- Metastasizing Tumor Cells
- Apoptosis
- Resistance to Chemotherapy
Stem Cell Classification
- Based on Ability to Differentiate
- Based on Source
Mechanism of Action
- Targeting Signaling Pathways
- Targeting CSCs Markers
- Targeting miRNA Expression
- Targeting CSCs' Niche
Stem Cell Transplants
- Autologous
- Allogeneic
- Syngeneic
Cancer Stem Cell Clinical Pipeline
Chapter 4 Market Dynamics
Market Dynamics
Drivers
- Increase in Cancer Research Activities
- Increase in Incidence and Mortality Rate of Cancer
Restraints
- Ethical Issues
- High Cost Associated with Cancer Stem Cell Therapeutics
Opportunity
- Increasing Cancer Stem Cell Research
- Successful Implementation of CSC as a Therapeutic Tool in Animals
Chapter 5 Market Breakdown by Cancer Type
Lung Cancer
- Incidence of Lung Cancer
- Risk Factors
- Types of Lung Cancer
- Site of Lung Tumor Initiation
- Lung Cancer Stem Cells as Therapeutic Targets
Breast Cancer
- Incidence and Mortality Rate of Breast Cancer
- Types of Breast Cancer
- Site of Tumor Initiation
- Breast Cancer Stem Cells as Therapeutic Targets
Colorectal Cancer
- Incidence and Mortality of Colorectal Cancer
- Colorectal Cancer Stem Cells as Therapeutic Targets
Leukemia
- Incidence and Mortality of Leukemia
- Leukemia Stem Cells as Therapeutic Targets
Melanoma
- Incidence and Mortality of Melanoma
- Melanoma Cancer Stem Cells as Therapeutic Targets
Prostate Cancer
- Incidence and Mortality Rate of Prostate Cancer
- Prostate Cancer Stem Cells as Therapeutic Targets
Brain Cancer
- Incidence of Brain Cancer
- Brain Cancer Stem Cells as Therapeutic Targets
Bone Cancer
- Bone Cancer Stem Cells as Therapeutic Targets
Others
Chapter 6 Market Breakdown by Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
Rest of the World (RoW)
- Brazil
- GCC Countries
- Rest of the World Countries
Chapter 7 COVID-19 and Stem Cell Research
Impact of Early-Stage Research
Advancing Stem Cells to Mainstream Medicines for COVID-19
The Future of Stem Cells for the Treatment of COVID-19
Chapter 8 Cost of Stem Cell Therapy in 2021
Types of Stem Cell Therapy
Stem Cell Therapy is Expensive- Why?
Ethics and Regulations for Stem Cell Therapy
Chapter 9 Competitive Landscape
Global Company Ranking Analysis
Start-up on Regenerative Therapeutics or Stem Cell Therapeutics
Chapter 10 Company Profiles
ADNAGEN AG
ADVANCED CELL DIAGNOSTICS INC.
APCETH BIOPHARMA
AVIVA BIOSCIENCES CORP.
BIONTECH
BENITEC BIOPHARMA
CALADRIUS BIOSCIENCES
CELGENE CORP.
EPIC SCIENCES INC.
EXCELLTHERA
FLUXION BIOSCIENCES INC.
GALENA BIOPHARMA
GAMIDA CELL
GENEXINE
GERON
IMMUNOCELLULAR THERAPEUTICS
ONCOCYTE CORP.
ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.
SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICS LTD.
VIACYTE INC.
VITATEX INC.
Chapter 11 List of Patents
North American Patents on Cancer Stem Cells
European Patents on Cancer Stem Cells
Asia-Pacific Patents on Cancer Stem Cells
RoW Patents on Cancer Stem Cells
Chapter 12 Appendix: Acronyms
List of Tables
Summary Table : Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 1 : Clinical Trials on Cancer Stem Cells
Table 2 : Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 3 : Global Market for Cancer Stem Cells for Lung Cancer, by Region, Through 2026
Table 4 : Global Market for Cancer Stem Cells for Breast Cancer, by Region, Through 2026
Table 5 : Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, Through 2026
Table 6 : Global Market for Cancer Stem Cells for Leukemia, by Region, Through 2026
Table 7 : Global Market for Cancer Stem Cells for Melanoma, by Region, Through 2026
Table 8 : Global Market for Cancer Stem Cells for Prostate Cancer, by Region, Through 2026
Table 9 : Global Market for Cancer Stem Cells for Brain Cancer, by Region, Through 2026
Table 10 : Global Market for Cancer Stem Cells for Bone Cancer, by Region, Through 2026
Table 11 : Global Market for Cancer Stem Cells for Other Cancers, by Region, Through 2026
Table 12 : Global Market for Cancer Stem Cells, by Region, Through 2026
Table 13 : North American Market for Cancer Stem Cells, by Country, Through 2026
Table 14 : North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 15 : European Market for Cancer Stem Cells, by Country, Through 2026
Table 16 : European Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 17 : Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
Table 18 : Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 19 : RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
Table 20 : RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 21 : Countries Where Stem Cell Research is Most Prevalent
Table 22 : Adnagen: Product Portfolio
Table 23 : Advanced Cell Diagnostics: Product Portfolio
Table 24 : Apceth Biopharma: Product Portfolio
Table 25 : Aviva Biosciences: Product Portfolio
Table 26 : BioNTech: Product Portfolio
Table 27 : Benitec Biopharma: Product Portfolio
Table 28 : Caladrius Biosciences: Product Portfolio
Table 29 : Celgene Corp.: Product Portfolio
Table 30 : Epic Sciences: Product Portfolio
Table 31 : ExCellThera: Product Portfolio
Table 32 : Fluxion Biosciences: Product Portfolio
Table 33 : Galena Biopharma: Product Portfolio
Table 34 : Gamida Cell: Product Portfolio
Table 35 : Genexine: Product Portfolio
Table 36 : Geron: Product Portfolio
Table 37 : ImmunoCellular Therapeutics: Product Portfolio
Table 38 : OncoCyte: Product Portfolio
Table 39 : OncoMed: Product Portfolio
Table 40 : Pluristem Therapeutics: Product Portfolio
Table 41 : Silicon Biosystems: Product Portfolio
Table 42 : Sphere Fluidics: Product Portfolio
Table 43 : ViaCyte Inc.: Product Portfolio
Table 44 : Vitatex: Product Portfolio
Table 45 : List of North American Patents on Cancer Stem Cells
Table 46 : List of European Patents on Cancer Stem Cells
Table 47 : List of Asia-Pacific Patents on Cancer Stem Cells
Table 48 : List of Row Patents on Cancer Stem Cells
Table 49 : Acronyms Used in This Report
List of Figures
Summary Figure : Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 1 : Classification of Stem Cells Based on Source
Figure 2 : Classification of Stem Cells Based on Source and Marker
Figure 3 : Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
Figure 4 : Incidence of Cancer, 2020
Figure 5 : Mortality of Cancer, 2020
Figure 6 : Major Issue in Stem Cell Research in Iran, 2017
Figure 7 : Number of New Cancer Cases and Mortality Rates Worldwide, by Cancer Type 2020
Figure 8 : Global Segmentation of the Market for Cancer Stem Cells, by Cancer Type
Figure 9 : Global Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 10 : Distribution of New Cases of Lung and Bronchus Cancer, by Age Group, 2020
Figure 11 : Global Market for Lungs Cancer in Cancer Stem Cells, by Region, 2019-2026
Figure 12 : Distribution of Female Breast Cancer Cases, by Stage at Diagnosis
Figure 13 : Breast Cancer Rates in Top Countries, 2020
Figure 14 : Global Market for Cancer Stem Cells for Breast Cancer, by Region, 2019-2026
Figure 15 : Incidence of Colorectal Cancer Among More and Less Developed Regions, 2018
Figure 16 : Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, 2019-2026
Figure 17 : Incidence and Mortality Rates of Leukemia in the U.S., 2010-2019
Figure 18 : Global Market for Cancer Stem Cells for Leukemia, by Region, 2019-2026
Figure 19 : Incidence and Mortality Rates of Melanoma in U.S., 2010-2019
Figure 20 : Global Market for Cancer Stem Cells for Melanoma, by Region, 2019-2026
Figure 21 : Distribution of New Cases of Melanoma in the U.S., by Age Group, 2021
Figure 22 : Global Market for Cancer Stem Cells for Prostate Cancer, by Region, 2019-2026
Figure 23 : Global Market for Cancer Stem Cells for Brain Cancer, by Region, 2019-2026
Figure 24 : Global Market for Cancer Stem Cells for Bone Cancer, by Region, 2019-2026
Figure 25 : Global Market for Cancer Stem Cells for Other Types of Cancer, by Region, 2019-2026
Figure 26 : Global Market Shares of Cancer Stem Cells, by Region, 2020
Figure 27 : Five Most Common Sites for Estimated New Cancer Cases and Death in U.S., 2021
Figure 28 : North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 29 : New Cases of Cancer in Males in the U.S., 2020
Figure 30 : New Cases of Cancer in Females in the U.S., 2020
Figure 31 : U.S. Market for Cancer Stem Cells, 2019-2026
Figure 32 : Distribution of New Cancer Cases in Canada, 2021
Figure 33 : Canadian Market for Cancer Stem Cells, 2019-2026
Figure 34 : Cancer Incidence and Mortality in Mexico, 2021
Figure 35 : Mexican Market for Cancer Stem Cells, 2019-2026
Figure 36 : Predicted Cancer Mortality in Europe, 2021
Figure 37 : European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 38 : Cancer Incidence and Mortality in Germany, 2020
Figure 39 : German Market for Cancer Stem Cells, 2019-2026
Figure 40 : Cancer Incidence and Mortality in France, 2018
Figure 41 : French Market for Cancer Stem Cells, 2019-2026
Figure 42 : Cancer Incidence in the U.K., 2018
Figure 43 : U.K. Market for Cancer Stem Cells, 2019-2026
Figure 44 : Cancer Incidence in Italy, 2020
Figure 45 : Italian Market for Cancer Stem Cells, 2019-2026
Figure 46 : Cancer Incidence in Spain, 2018
Figure 47 : Spanish Market for Cancer Stem Cells, 2019-2026
Figure 48 : Rest of European Market for Cancer Stem Cells, 2019-2026
Figure 49 : Shares of Top Five Countries with Cancer Cases in Asia, 2018
Figure 50 : Cancer Incidence in Southeast Asia, 2020
Figure 51 : Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 52 : Cancer Incidence in Japan, by Cancer Type, 2020
Figure 53 : Cancer Deaths in Japan, by Cancer Type, 2020
Figure 54 : Budget to Control Cancer in Japan, 2003-2015
Figure 55 : Japanese Market for Cancer Stem Cells, 2019-2026
Figure 56 : Cancer Incidence and Mortality in China, 2020
Figure 57 : Chinese Market for Cancer Stem Cells, 2019-2026
Figure 58 : Cancer Incidence and Mortality in Australia, 2020
Figure 59 : Australian Market for Cancer Stem Cells, 2019-2026
Figure 60 : Cancer Incidence and Mortality in India, 2020
Figure 61 : Indian Market for Cancer Stem Cells, 2019-2026
Figure 62 : Rest of Asia-Pacific Market for Cancer Stem Cells, 2019-2026
Figure 63 : Distribution of New Cancer Cases in Latin America and the Caribbean, by Cancer Type, 2020
Figure 64 : Distribution of Cancer Deaths in Latin America and the Caribbean, by Cancer Type, 2020
Figure 65 : RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 66 : Cancer Incidence and Mortality in Brazil, 2020
Figure 67 : Brazilian Market for Cancer Stem Cells, 2019-2026
Figure 68 : Brazilian Market for Cancer Stem Cells, 2019-2026
Figure 69 : Most Common Cancer Cases in Qatar, by Incidence and Mortality, 2020
Figure 70 : GCC Countries Market for Cancer Stem Cells, 2019-2026
Figure 71 : Other Countries Market for Cancer Stem Cells, 2019-2026
Figure 72 : Using MSC Therapy in COVID-19 Patients
Figure 73 : How Much Does Stem Cell Therapy Cost?
Figure 74 : Global Ranking in the Market for Cancer Stem Cells, by Pharmaceutical Company, 2020
Figure 75 : Global Ranking in the Market for Cancer Stem Cells, by Start-up Pharmaceutical Company, 2020